Search Results 941-950 of 18954 for Neutrophil

1. A Study of ART24 in Subjects Recently Cured of a Clostridioides difficile Infection (CDI) - Mayo Clinic

   Absolute neutrophil count 1.8 mg/dL. Use of systemic antibiotic therapy for conditions other than CDI within 7 days of randomization or expectation to ...

2. A Study of Lenvatinib for Treating Patients with Metastatic or Advanced Pheochromocytoma or Paraganglioma that Cannot be Removed by Surgery - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; White blood cell (WBC) count ≥ 3,000/mm^3; Platelet count ≥ 100,000/mm^3; Hemoglobin ≥ 9.0 g/dL (5.6 mmol/L); ...

3. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) >1000/mm^3;; Absolute lymphocyte count (ALC) >300/mm^3;; Absolute number of CD3+ T cells >150/mm^3;; Platelets ≥50000/mm^3 ...

4. A Study to Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy for Patients with Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1500/mm^3;; Platelet count 100,000/mm^3;; Total bilirubin ≤ 1.5 upper limit of normal (ULN), or if total bilirubin is > 1.5 ...

5. Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma - Mayo Clinic

   Absolute neutrophil count (ANC) >= 1,500/mm^3; Platelet count >= 100,000/mm^3; Creatinine =< 1.5 x upper limit of normal (ULN); Total bilirubin =< 1.5 x upper ...

6. A Study of ONC201 for Patients with H3 K27M-mutant and/or Midline High Grade Gliomas - Mayo Clinic

   Absolute neutrophil count ≥ 1,000/mm^3 without growth factor use ≤ 7 days prior to treatment (cycle 1 day 1, C1D1);; Hemoglobin > 8.0 mg/dL without red ...

7. Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery - Mayo Clinic

   Absolute neutrophil count >= 1,500/mm^3; Platelets >= 100,000/mm^3; Total bilirubin =< the upper limit of normal (ULN); Calculated creatinine clearance must be > ...

8. Bemarituzumab plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone - Mayo Clinic

   - Absolute neutrophil count ≥ 1.5 x 10^9/L - Platelet count ≥ 100 x 10^9/L - Hemoglobin ≥ 9 g/dL without red blood cell (RBC) transfusion within 7 days ...

9. A Study to Evaluate Fostamatinib Disodium to Treat Warm Antibody Autoimmune Hemolytic Anemia - Mayo Clinic

   Subject has one or more of the following laboratory abnormalities at screening: neutrophil count of <1,000/μL or platelet count of < 30,000/μL, unless due ...

10. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    Absolute neutrophil count ≥ 1,500 cells/μL;; Platelets* ≥ 100,000 cells/μL;; Hemoglobin* ≥ 9 g/dL or ≥ 5.6 mmol/L. Renal. Creatinine ≤ 1.5 × ULN; OR ...